Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose.
diabetes
fasting serum insulin
impaired fasting glucose
non-alcoholic fatty liver disease
serum alanine aminotransferase
urinary albumin excretion
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Sep 2020
29 Sep 2020
Historique:
received:
24
08
2020
revised:
19
09
2020
accepted:
22
09
2020
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
3
10
2020
Statut:
epublish
Résumé
We examined the association between non-alcoholic fatty liver disease (NAFLD) markers and fasting serum immunoreactive insulin (FIRI) and urinary albumin excretion (UAE). This study comprised Periods I and II from January 2007 to May 2009, and from June 2009 to December 2011, respectively. After excluding people with ethanol intake ≥210 g/week in men and ≥140 g/week in women, 961 people (613 men, 348 women; mean age: 44 years) were included. We evaluated the fatty liver using ultrasonography score (FLUS) and measured liver enzymes. The mean observation period was 25 ± 9 months. We stratified people into two groups by fasting plasma glucose (FPG) in Period I. The cutoff point between the lower FPG and higher FPG was 100 mg/dL. In regression analysis, serum alanine aminotransferase (ALT) ( Some NAFLD markers were associated with FIRI and UAE independently of fasting plasma glucose.
Identifiants
pubmed: 33003574
pii: jcm9103161
doi: 10.3390/jcm9103161
pmc: PMC7650561
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Hepatol. 2010 Aug;53(2):372-84
pubmed: 20494470
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Diabetes Res Clin Pract. 2014 Jun;104(3):459-66
pubmed: 24742930
Diabetes Care. 2008 Jun;31(6):1138-43
pubmed: 18346992
Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1714-5
pubmed: 21775769
J Clin Ultrasound. 1996 Jan;24(1):25-9
pubmed: 8655663
Circulation. 2002 Oct 1;106(14):1777-82
pubmed: 12356629
Hypertens Res. 2003 May;26(5):413-9
pubmed: 12887133
Diabetologia. 2004 Jul;47(7):1245-1256
pubmed: 15241592
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Diabetologia. 2011 May;54(5):1004-12
pubmed: 21153531
Intern Med. 2007;46(14):1079-82
pubmed: 17634703
Diabetes Care. 2003 Mar;26(3):725-31
pubmed: 12610029
Eur Heart J. 2011 Jul;32(14):1769-818
pubmed: 21712404
J Nephropathol. 2013 Oct;2(4):234-40
pubmed: 24475455
Am J Gastroenterol. 2010 Nov;105(11):2389-95
pubmed: 20628364
Hepatology. 2014 Jun;59(6):2178-87
pubmed: 24777953
Diabetes Res Clin Pract. 2014 Jun;104(3):451-8
pubmed: 24785738
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Diabetes. 2005 Nov;54(11):3140-7
pubmed: 16249437
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
BMJ. 2004 Apr 24;328(7446):983
pubmed: 15028636
Diabetes Res Clin Pract. 2011 Apr;92(1):46-52
pubmed: 21242013
Metabolism. 2007 Dec;56(12):1708-13
pubmed: 17998025
Clin Chim Acta. 2018 Jun;481:231-237
pubmed: 28818597
Pharmaceuticals (Basel). 2018 Nov 08;11(4):
pubmed: 30413050
Clin Chem. 2008 Feb;54(2):234-7
pubmed: 18223130
J Intern Med. 2001 Dec;250(6):502-7
pubmed: 11902818
Prim Care Diabetes. 2016 Feb;10(1):19-26
pubmed: 26303223
J Clin Lipidol. 2015 Mar-Apr;9(2):129-69
pubmed: 25911072
J Hepatol. 2008 Jul;49(1):115-22
pubmed: 18462825
J Int Med Res. 2014 Apr;42(2):542-53
pubmed: 24595150